Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

A role for interleukin-22 in the alleviation of metabolic syndrome

Nature Medicine volume 20, pages 1379–1381 (2014)Cite this article

Subjects

Increasing evidence points to a role for the immune system in the regulation of metabolism. Two new studies in mice indicate treatment with interleukin-22 restores mucosal immunity in diabetes and alleviates metabolic disease, resulting in improved glycemic control.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: The effects of IL-22.

Katie Vicari/Nature Publishing Group

References

  1. Donath, M.Y. Nat. Rev. Drug Discov. 13, 465–476 (2014).

    Article  CAS  Google Scholar 

  2. Hasnain, S.Z. et al. Nat. Med. 20, doi:10.1038/nm.3705 (2 November 2014).

  3. Wang, X. et al. Nature 514, 237–241 (2014).

    Article  CAS  Google Scholar 

  4. Cani, P.D., Geurts, L., Matamoros, S., Plovier, H. & Duparc, T. Diabetes Metab. 40, 246–257 (2014).

    Article  CAS  Google Scholar 

  5. Tremaroli, V. & Backhed, F. Nature 489, 242–249 (2012).

    Article  CAS  Google Scholar 

  6. Colonna, M. Immunity 31, 15–23 (2009).

    Article  CAS  Google Scholar 

  7. Maedler, K. et al. J. Clin. Invest. 110, 851–860 (2002).

    Article  CAS  Google Scholar 

  8. Zhou, R., Tardivel, A., Thorens, B., Choi, I. & Tschopp, J. Nat. Immunol. 11, 136–140 (2010).

    Article  CAS  Google Scholar 

  9. Sabat, R., Ouyang, W. & Wolk, K. Nat. Rev. Drug Discov. 13, 21–38 (2014).

    Article  CAS  Google Scholar 

  10. Winer, S. et al. Nat. Med. 15, 921–929 (2009).

    Article  CAS  Google Scholar 

  11. Dalmas, E. et al. Diabetes 63, 1966–1977 (2014).

    Article  CAS  Google Scholar 

  12. Fabbrini, E. et al. Gastroenterology 145, 366–374. e1–e3 (2013).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. and the Department of Biomedicine, Elise Dalmas and Marc Y. Donath are in the Clinic of Endocrinology, Diabetes and Metabolism, University of Basel, Basel, Switzerland.,

    Elise Dalmas & Marc Y Donath

Authors
  1. Elise Dalmas
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Marc Y Donath
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Marc Y Donath.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dalmas, E., Donath, M. A role for interleukin-22 in the alleviation of metabolic syndrome. Nat Med 20, 1379–1381 (2014). https://doi.org/10.1038/nm.3748

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm.3748

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing